Biochemical Milieu in Intrahepatic Cholestasis of Pregnancy and Its Improvement with Ursodeoxycholic Acid

Key Points

• To evaluate the effectiveness of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy.
• Administered UDCA to pregnant individuals diagnosed with IHCP.
• Monitored biochemical parameters and symptoms throughout treatment.
• Assessed maternal and fetal outcomes.
• UDCA treatment significantly reduced pruritus symptoms.
• Improved biochemical markers related to liver function.
• Enhanced overall outcomes for both mother and fetus.